Free CME from PeerView


Hematology CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
Anthony R. Mato, MD, MSCE
September 9, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
Ian W. Flinn, MD, PhD
September 7, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP
August 25, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Redrawing the Algorithm in Gastric and GEJ Cancers: Treatment Planning and Sequencing in the Era of Immunotherapy
Manish A. Shah, MD, FASCO
August 23, 2021
Credits: 1.00 NCPD
Medical Learning Institute, Inc.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
August 18, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
August 10, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers
Jaffer A. Ajani, MD / Ian Chau, MD, FRCP
July 9, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
Suzanne Lentzsch, MD, PhD
July 9, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
Nina Shah, MD
July 7, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in Advanced and Early HR+ Breast Cancer: Expert Perspectives on CDK4 and 6 Inhibitors and Other Novel Agents
Sara M. Tolaney, MD, MPH
July 7, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 7, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
Deborah K. Armstrong, MD
July 6, 2021
Credits: 1.50 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
Stephen V. Liu, MD
July 6, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
Toni K. Choueiri, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
Jacob Sands, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
Gail J. Roboz, MD
July 5, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity
Sara Hurvitz, MD
July 2, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer
Joyce O’Shaughnessy, MD
July 2, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Pushing Therapeutic Boundaries in CLL: The Convergence of Targeted Therapy, Novel Combinations, and Precision Medicine in Patient Care
Matthew S. Davids, MD, MMSc
July 2, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Achieving Therapeutic Innovation in ALL: Insights on Modern Asparaginase Compounds in Pediatric, AYA, and Adult Patients
Nicola Gökbuget, MD
June 30, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices
William G. Wierda, MD, PhD
June 29, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Teaming Up to Overcome Challenges in the Diagnosis and Management of Noninfectious Uveitis: Enhancing Multidisciplinary Care in the Biologic Therapy Era
James T. Rosenbaum, MD
June 28, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
Karl D. Lewis, MD
June 25, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
Matthew D. Galsky, MD
June 23, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
Stuart H. Isaacson, MD
June 22, 2021

Pages

Upcoming Live Events

Education Collections


Recent CME Podcast

More Podcasts from PeerView